Effects of group housing on ECG assessment in conscious cynomolgus monkeys.

INTRODUCTION Assessing the cardiovascular safety of new chemical or biological entities is important during pre-clinical development. Electrocardiogram (ECG) assessments in non-human primate (NHP) toxicology studies are often made using non-invasive telemetry systems. We investigated whether ECG recording was feasible during group housing of NHPs, rather than the usual single housed arrangement, and whether it would impact the data collected or affect the ability to detect drug-induced changes in QTc interval. METHODS Following a period of acclimatisation to jackets, cynomolgus monkeys (3 males and 3 females) were housed in same sex groups of 3. Female monkeys were administered 4 doses of vehicle while male monkeys were administered vehicle, 15, 45, and 135mg/kg moxifloxacin. Each dose was administered on a separate dosing day. The same dosing protocol was repeated with the animals singly housed and the results from the two phases were compared including assessment of statistical power. RESULTS Heart rate (HR) was significantly lower, and PR and QT intervals were significantly higher, at multiple time points when the animals were group housed compared with the singly housed phase. QRS duration and QTc interval were less affected. Moxifloxacin increased QT and QTc intervals but had no consistent effect on HR, QRS duration or PR interval under group housed or singly housed conditions. Power analysis suggested that group housing did not adversely affect the magnitude of detectable changes of ECG parameters. In general, detection of slightly smaller changes was achieved under conditions of group housing. DISCUSSION The current study shows group housing to be technically possible during non-invasive ECG recording, resulting in lower resting heart rates and small improvements in sensitivity of detection of drug-induced effects. Given the psychological benefits of group housing for NHPs, it is a refinement that should be considered when conducting ECG assessments in NHP toxicology studies.

[1]  Jennifer Sims,et al.  The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates. , 2012, Regulatory toxicology and pharmacology : RTP.

[2]  J. Wyatt,et al.  Pair housing of macaques in research facilities: a science-based review of benefits and risks. , 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.

[3]  T. Baird,et al.  Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium. , 2014, Journal of pharmacological and toxicological methods.

[4]  H. Vargas,et al.  Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants. , 2009, Journal of pharmacological and toxicological methods.

[6]  Thomas Trautmann,et al.  Optimizing the experimental environment for dog telemetry studies. , 2006, Journal of pharmacological and toxicological methods.

[7]  Michael D B Swedberg,et al.  A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions. , 2013, Journal of pharmacological and toxicological methods.

[8]  D. Gauvin,et al.  Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving cynomolgus monkey by remote radiotelemetry. , 2006, Journal of pharmacological and toxicological methods.

[9]  Jean-Pierre Valentin,et al.  Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs. , 2009, Journal of pharmacological and toxicological methods.

[10]  D J Gallacher,et al.  Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: current recommendations from the Safety Pharmacology Society. , 2012, Journal of pharmacological and toxicological methods.

[11]  Hugo M Vargas,et al.  Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals , 2013, Expert opinion on drug safety.

[12]  Hugo M Vargas,et al.  Safety pharmacology investigations in toxicology studies: an industry survey. , 2013, Journal of pharmacological and toxicological methods.

[13]  W Suter,et al.  How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? , 2011, British journal of pharmacology.

[14]  C. Shively,et al.  Effects of chronic social separation on cardiovascular disease risk factors in female cynomolgus monkeys. , 1998, Atherosclerosis.

[15]  M. Kenward,et al.  Small sample inference for fixed effects from restricted maximum likelihood. , 1997, Biometrics.

[16]  A. Bass,et al.  Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures. , 2009, Journal of pharmacological and toxicological methods.

[17]  W. Gu,et al.  Detection of QTc interval prolongation using jacket telemetry in conscious non‐human primates: comparison with implanted telemetry , 2014, British journal of pharmacology.

[18]  Jean-Pierre Valentin,et al.  Functional assessments in repeat-dose toxicity studies: the art of the possible , 2013 .